Skip to main content
Dialogues in Clinical Neuroscience logoLink to Dialogues in Clinical Neuroscience
. 2002 Sep;4(3):305–319. doi: 10.31887/DCNS.2002.4.3/jcottraux

Nonpharmacological treatments for anxiety disorders

Tratamientos no fannacológicos para los trastornos de ansiedad

Traitements non pharmacologiques des troubles anxieux

Jean Cottraux 1,*
PMCID: PMC3181686  PMID: 22034140

Abstract

An evidence-based review of nonpharmacological treatments for anxiety disorders is presented. The vast majority of the controlled research is devoted to cognitive behavior therapy (CBT) and shows its efficiency and effectiveness in all the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) anxiety disorders in meta-analyses. Relaxation, psychoanalytic therapies, Rogerian nondirective therapy, hypnotherapy and supportive therapy were examined in a few controlled studies, which preclude any definite conclusion about their effectiveness in specific phobias, agoraphobia, panic disorder, obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD), CBT was clearly better than psychoanalytic therapy in generalized anxiety disorder (GAD) and performance anxiety Psychological debriefing for PTSD appeared detrimental to the patients in one high-quality meta-analysis. Uncontrolled studies of psychosurgery techniques for intractable OCD demonstrated a limited success and detrimental side effects. The same was true for sympathectomy in ereutophobia. Transcranial neurostimulation for OCD is under preliminary study. The theoretical and practical problems of CBT dissemination are discussed.

Keywords: anxiety disorder, meta-analysis, controlled trial, cognitive-behavior therapy, psychological therapy, debriefing, psychosurgery


Nonpharmacological treatments for anxiety disorders - although of varied orientations - are unequally represented in the literature. The bulk of the research is devoted to behavior therapy (BT) and, more recently, to cognitive therapy (CT) methods. Both CT and BT techniques are used in combination by the vast majority of clinicians and researchers under the label of cognitive behavior therapy (CBT). Relaxation methods have been used as the main technique in anxiety disorders or studied as a control condition in some randomized controlled trials (RCTs). Some relaxation techniques, such as Ost's applied relaxation,1-3 are in fact made of several cognitive and behavioral techniques. Psychoanalytic (or psychodynamic) therapies, hypnotherapy, Rogerian nondirective therapy, supportive therapy (ST), and psychological debriefing for posttraumatic stress disorder (PTSD) have been evaluated in RCTs and meta-analyses. Transcranial neurostimulation and psychosurgery techniques have been studied in obsessive-compulsive disorders (OCDs). Some preliminary data exist for sympathectomy in ereutophobia. Hence an evidence-based review of all these nonpharmacological methods is possible.

Panic disorder and agoraphobia

CBT in panic disorder and agoraphobia

Panic disorder and agoraphobia are treated using two basic strategies: exposure (in imagination and in vivo or interoceptive exposure) and cognitive restructuring.

Exposure principle

Exposure in vivo represents the final common pathway of many techniques described by several schools of psychotherapy. The first, person to write a report, on successful exposure in agoraphobia was a French author, Perroud4 who was working at the Hôpital de la Charité, in Lyon. Janet5 used the exposure principle in several cases of obsessions or phobias. Later, Freud6 made a. forgotten contribution to CBT with the straightforward judgement that for resistant agoraphobia “one succeeds only when one can induce them by the influence of the analysis to go into the street and to struggle with their anxiety.” In this respect, cognitive behavior therapists arc more Freudian than modern psychoanalysts, who continue to treat agoraphobia with classic psychoanalysis, while its effectiveness remains to be demonstrated.

Wolpe7 and Marks,8 a fervent reader of Janet, systematically developed the exposure paradigm in anxiety disorders and put. this principle under systematic scientific inquiry, in several controlled trials, which were replicated all over the world.

Exposure consists in habituating degree by degree the patient to the feared situations in imagination and then in vivo. The aim is to obtain a habituation of emotional responses and the extinction of avoidance behaviors, which are reinforced by anxiety. Generally, the therapy starts with exposure in imagination confronting the patient, step by step to the feared situations until habituation occurs. Graded in vivo exposure is then carried out. Each session of exposure in vivo or in imagination may last up to 45 minutes, which is, in general, the maximum length of time required to habituate the anxiety responses.

Cognitive restructuring

CT implements two main strategies: (i) cognitive restructuring on misinterpretations of bodily sensations; and (ii) breathing retraining in order to control the physiological effects of hyperventilation and tachycardia. Treatment, typically includes 15 to 20 sessions, which can be summarized as follows:

  • Modifying panic attacks, (i) Breathing retraining to control the sensations resulting from hyperventilation frequently involved in panic attacks; (ii) Valsalva technique through abdominal breathing to control tachycardia; and (iii) cognitive restructuring to modify misinterpretations of bodily sensations and challenge the danger cognitive schemata.

  • Modifying agoraphobia. Behavioral experiments consist, in modifying avoidance behaviors through graded exposure followed by cognitive restructuring through self-talk and written disputing on appropriate forms.

Interoceptive exposure for panic attacks

Some researchers designed specific techniques for the bodily symptoms. Panic control treatment9 consists of three major strategies: (i) cognitive restructuring; (ii) breathing retraining; and (iii) interoceptive or structured exposure to bodily sensations that, have become associated with panic attacks.

Since physical sensations often trigger conditioned anxiety, the procedure of interoceptive exposure attempts to extinguish anxiety connected with these bodily sensations. Identifying “interoceptive avoidance,” or avoidance of situations that might, provoke specific physical sensations and their catastrophic cognitive appraisal, is implemented during the therapy. These situations are not identical to agoraphobic situations and may include watching frightening movies or driving with the windows closed. All patients are presented with exercises meant, to induce physical sensations: running on the spot, being spun in a swivel chair, breathing through a narrow straw, etc. Patients are then encouraged to enter naturalistic situations that might be associated with the elicitation of physical sensations that are particularly anxiety-provoking.

Outcomes of exposure treatments

Meta-analyses on panic disorder10-13 found that in vivo exposure was a critical component of treatment, but disagreed on its results in combination with antidepressants, anxiolytic drugs, and cognitive interventions. Van Balkom et al's13 meta-analysis and its follow-up study by Bakker et al'14 suggested that the most, effective treatment, was a. combination of exposure in vivo and antidepressants. Another meta-analysis by Gould et al15 found a higher size effect for CBT than for pharmacotherapy and a combination of medication with therapy, with the lowest, dropout, rate and the best, cost-effectiveness ratio. Table I presents the outcomes of Gould et al's15 meta analysis. Interoceptive exposure appears to be the most, effective technique.

Table I. Panic disorder: meta-analysis of size effects.15 CT, cognitive therapy; CBT, cognitive behavior therapy.
Therapy Size effect
CT + interoceptive exposure 0.88
CBT 0.68
Pharmocological treatment 0.47
Pharmocological treatment + CBT 0.56
Antidepressants 0.55
Benzodiazepines 0.40

Outcomes at follow-up

O'Sullivan and Marks16 conducted a review of 10 long-term follow-ups (the longest, lasted 9 years). Four hundred and forty-seven patients out. of a panel of 553 had been followed up in controlled studies for a mean duration of 4 years. They found a 76% improvement in the cumulated samples with residual symptoms as a. rule; 15% to 25% of the patients continued to have depressive episodes after treatment. In the longer follow-ups, up to 50% consulted practitioners for their psychological problems and 25% saw psychiatrists for depression and/or agoraphobia. However, the consultation rate decreased.

CBT and medication: combination studies

Combination allows stopping the medication without, the very high relapse rate that is found in drug-only studies. However, a positive interaction was found only with certain antidepressant drugs (imipramine, fluvoxamine, and paroxetine) and anxiolytic drugs (buspirone). Moreover, CBT facilitates the withdrawal of benzodiazepines (BDZs). One may summarize the outcomes of the combination studies as follows:

  • Positive interactions with antidepressants were reported in seven controlled studies.17-23

  • No interaction with antidepressants was found in five studies/24'28

  • Short-term positive interaction and long-term negative interaction of exposure in vivo with high doses of alprazolam (6 mg) was found by Marks et al29 and Wardle et al.30

  • Short-term positive interaction of exposure in vivo with low doses of diazepam (<30 mg) was found in a controlled study. However, there was a transient withdrawal syndrome. No negative long-term effects.31

  • Short-term positive interaction of CBT with low doses of buspirone (<30 mg) on agoraphobia and generalized anxiety was demonstrated in a controlled study. No withdrawal syndrome and no long-term negative effects appeared. The effect, of buspirone on agoraphobia correlated with its effects on depressive cognition. Buspirone's action on agoraphobic behaviors is probably mediated by the reduction of both anxiety and depression.32

  • CBT facilitated BDZ withdrawal in two controlled studies.33,34

Relaxation in panic disorder and agoraphobia

CT appeared to be superior to Jacobson's relaxation in one trial.35 In a 2-year follow-up study, Craske et al35 suggested that Jacobson's relaxation could even impede the positive effects of BT.

Clark et al36 found that CBT (84%) was superior to relaxation (40%), imipramine with a maximum dose of 300 mg/day (42%), and a waiting list. The follow-up of this study was 1 year. At this point, all intention-to-treat groups received self-exposure instructions. This study confirmed the superiority of CBT over relaxation and also suggested that imipramine, the reference drug, was neither the only effective treatment, nor the most efficient.

Applied relaxation1-3 has been found to be as effective as CBT in panic disorder with agoraphobia. However, it. contains cognitive coping strategies, as well as exposure assignments. Accordingly, the applied relaxation format is more a variant, of CBT than a pure relaxation technique. This is confirmed by the fact that applied relaxation appeared better than Jacobson's relaxation in one controlled trial.37 Nevertheless, applied relaxation was superior to a waiting list, but inferior to CT in another trial dealing with panic disorder without agoraphobia.38

ST in panic disorder

In a controlled study, Beck et al39 reported a rate of 71 % panic-free patients after 8 weeks of CT versus 25% after 8 weeks of ST. It is worth noting that 94% of the patients who were randomized to ST chose to have CT after ST. At. a 1-year follow-up 87% of the patients who had CT were panic-free versus 79% in the group who had ST first, and then CT. Beck et al's39 outcomes were at variance with those of Shear et al's40 controlled study, which found at. a. 6-month follow-up that CT and ST demonstrated positive and equivalent effects on panic attacks.

Psychodynamic therapy in panic disorder

To our knowledge, there is only one controlled study concerning panic disorder. Wiborg and Dahl41 compared clomipramine alone with psychodynamic therapy (15 sessions) associated with clomipramine in 80 subjects with panic disorder. Psychodynamic therapy was focused on dependence behaviors and related emotional problems. The randomization process did not work in that study: baseline Hamilton Anxiety, Hamilton Depression, and Handicap scales were significantly higher in the clomipramine group. Nevertheless, the authors contended that, the combined condition (20% relapses) was superior to clomipramine alone (75% relapses) at. a 9month follow-up. As there was no waiting-list control, Wiborg et al's41 study does prove a specific effect of psychodynamic therapy in panic disorder.

Generalized anxiety disorder

CBT in GAD

Methods

Since the first operational definition of generalized anxiety disorder (GAD) in the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III),42 the pathogenesis has been clearly concentrated on the concept of excessive worry.43 This cognitive point of view considers the somatic symptoms as secondary manifestations of cognitive processes. Later, the I) SM.-IV“4 paid allegiance to the cognitive model with another criterion: the difficulty in controlling the worry. This new trend was supported by numerous studies assessing normal and abnormal thoughts showing the intolerance to uncertainty of GAD subjects. Pathological worry is viewed as shaped by cognitive distortions, which result from maladaptive schemata of danger. Ruminations and attention disturbances impede normal problem solving in everyday situations and worry represents for the patient an inefficient way to control possible negative events in the future.45

In CBT, the patient is advised to consider his or her catastrophic view up to its ultimate consequences. At this point, Socratic questioning will help him or her substitute more probabilistic views instead. The patient can also be exposed in imagination to the catastrophic scenes to reach habituation. Then, basic schemata of danger are elicited and questioned. The treatment, format classically involves about. 15 sessions. The different. levels of intervention are cue-controlled relaxation, cognitive restructuring, problem solving, in vivo exposure to feared real-life situations, and exposure in imagination in order to obtain habituation to highly improbable situations. The aim is to replace the worry by effective coping strategies.

Outcomes

A meta-analysis by Gould et al46,47 found CBT and pharmacotherapy equally effective. This meta-analysis included 35 controlled studies, which had been published between 1974 and 1996: 13 studies dealt, with CBT and 22 with medication. The size effect was 0.70 for CBT and 0.60 for the pharmacological treatment. However, the drug samples had higher dropout, rates and showed a loss of efficacy at withdrawal, while the effects of CBT were maintained. Studies assessing the CBT plus drug combination were lacking.

Psychoanalytic therapy in GAD

Two studies reported negative outcomes for psychoanalytic therapies (Table II).48-53 In Durham et al's48 study psychoanalytic therapy had within-group positive effects, but these effects were significantly inferior to those of CBT immediately after the test, and at 1-year follow-up.

One should also mention that the psychoanalytic method used by White49 was less than optimal.

Rogerian nondirective therapy in GAD

Two studies reported equal effects of Rogerian therapy and CBT. Two reported a better effect of CBT. Further studies should be done to clarify this point. Table II also presents the outcomes of these four studies.50-53

Table II. Generalized anxiety disorder: cognitive behavior therapy (CBT) versus other therapies. ST, supportive therapy.

Outcome Duration of follow-up Reference
CBT versus psychoanalytic therapy
CBT > psychoanalytic therapy 1 year Durham et al,48 1994
CBT > psychoanalytic therapy White et al;49 1992
CBT versus Rogerian nondirective therapy
CBT > ST 6 months and 1 year Borkovec and Mathews.50 1987
CBT > ST 1 year Boricovec and Costello.51 1993
CBT = ST 6 months Blowers et al,52 1987
CBT = ST 6 months Stanley et al,53 1996

Posttraumatic stress disorder

CBT in PTSD

Methods

Treatment of PTSD is the center of a growing interest in the literature. Th erapeutic programs involve relaxation, which is beneficial in case of high emotional arousal, exposure to avoided situations or images related to the trauma, and CT. Five methods have been proposed. All the methods insist on the necessity of respecting the pace of the patient to reach the peak of the horror that, is at the center of the traumatic experience.

  • Systematic desensitization presents the feared stimuli in imagination under relaxation in a graded way prior to in vivo exposure.

  • Exposure in imagination and in vivo aims at habituating the patient to the aversive stimulus, by reducing abnormal reactivity and avoidance. In vivo exposure to the nondangerous situations being avoided is then suggested.

  • Stress management emphasizes the development, of coping strategies to deal with fears (relaxation, social skills training [SST], modification of anxious verbalization, or thought stopping).

  • Cognitive therapy also suggests exposure in imagination and representation of coping strategies, but puts a greater emphasis on dealing with automatic thoughts and dysfunctional attitudes (personalization, guilt, illusion of a safe world, and necessity of revenge).

  • Eye movement desensitization and reprocessing (EMDR) consists in inducing eye movements when concentrated on feared imagery, bodily sensations, and negative statements associated with the trauma, in order to reduce anxiety and hence modify cognition in a positive way.54 Sessions last. 90 minutes and are limited to 4 or 5. This method was hypothesized to work on neuropsychological functions. In fact, there is no clear evidence that EMDR is no more than a variant of the usual CBT programs. A controlled study55 found that EMDR with or without ocular movements gave the same positive outcomes as a standard psychiatric procedure at. posttest and a 6-month follow-up. Nonspecific factors might be implied in EMDR.

Outcomes: meta-analysis

Most, of the studies showed positive results. TTtierc is no difference in outcomes between CT and BT56 About 60% of patients respond to the treatment. Follow-up studies seldom exceed 6 months or 1 year.

Van Etten and Taylor57 conducted a meta-analysis of 61 treatment outcome trials for PTSD. Treatments included drug therapies (tricyclic antidepressants, carbamazepine, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors [SSRIs], and BDZs), psychological therapies (BT, EMDR, relaxation training, hypnotherapy, and psychodynamic therapy), and control conditions (pill placebo, waiting-list controls, supportive psychotherapies, and nonsaccade EMDR control). Psychological therapies demonstrated significantly lower dropout rates than pharmacotherapies (14% versus 32%). The attrition rate was uniformly low. Follow-up results were only available for BT and EMDR: outcome was maintained at 15-week follow-up.

Psychodynamic therapy and hypnotherapy in PTSD

Brom et al's58 randomized study compared systematic desensitization with psychodynamic therapy, hypnotherapy, and a waiting-list control in 112 patients. The results showed a reduction in symptoms in all three groups at posttest: improvement rate was 41% for systematic desensitization, 34% for hypnotherapy, and 29% for psychodynamic therapy. The between-group difference was nonsignificant. The study had no follow-up.

Debriefing for PTSD prevention

DSM-IV44 considers that 1 month of stress reaction is required to make a diagnosis of acute PTSD, and 6 months for chronic PTSD. Many subjects present, spontaneous remissions in the 1-month interval following the trauma. Debriefing was introduced by Mitchell59 as a short-term early intervention, which takes place in the immediate aftermath of the trauma (within 48 h).The aim is to reduce immediate posttraumatic distress and to prevent PTSD occurring through discussing and reliving the traumatic event, step by step. Debriefing consists of a single group or individual session that lasts 3 h. Typically, seven stages are implemented by a psychologist or in some cases by laypersons in a didactic format that, progressively reaches the emotional core of the trauma: “introduction,” “facts,” “thoughts,” “reactions,” “symptoms,” “teaching,” and “relating.”

Debriefing has been strongly advocated and widely used in many countries, but well-designed evaluative studies come out. with negative outcomes. A metaanalysis of 11 high-quality RCTs was carried out60 and found that, single-session debriefing did not reduce distress, depression, or anxiety, and did not prevent PTSD from occurring. Moreover, the risk of developing PTSD was higher in those patients who received debriefing, compared with those who did not, in one important trial. In conclusion, the authors stated that, compulsory debriefing should cease. It. seems that debriefing sensitizes the patients, rather than enhancing habituation process. It. may also represent a second trauma that “prints” the event in the autobiographical memory.

Patients with ruminations seem more likely to have negative reactions.

Obsessive-compulsive disorder

CBT in OCD

Methods

The main behavioral strategy is in vivo exposure with response prevention, which was initiated by Janet5 and developed by Meyer61 and Marks.8 Exposure with response prevention means that exposure is carried out. while compulsions are not allowed to the patient. The aim is to reach habituation to obsession-triggering stimuli. Nonetheless, it is less time-consuming and very costeffective to give homework assignments, which are agreed on with the patient. It is also helpful to involve the patient's partner as a cotherapist. For patients for whom the trigger is more internal, eg, fear of internal representation rather than environmental cues or having covert, rituals, prolonged exposure in imagination is the recommended procedure.

A cognitive behavioral model for OCD was proposed by Salkovskis.62 First, the intrusive thought, which is unacceptable and egodystonic, is viewed as a “normal” process failing to habituate for biological and/or psychological reasons. Second, the obsessive thought (automatic thought) is an evaluation of the intrusive ideas through overresponsibility schemata deep-seated in the long-term memory. This leads to rituals (overt behavior) and neutralizing thoughts (covert behavior), which represents an attempt to control and suppress intrusive thoughts. Such neutralizations prevent, habituation to intrusive thoughts from occurring. Hence, Salkovskis proposed a triple intervention: cognitive exposure to intrusive thoughts with neutralization prevention, Socratic questioning of the automatic thoughts and overresponsibility schemata, followed by behavioral experiments (in vivo exposure) to disconfirm the schemata. Treatment classically involves 20 to 25 sessions.

Results of BT

BT has been clearly demonstrated to be superior to placebo and relaxation. The outcome with BT is close to that of serotonergic antidepressants, which have detrimental side effects and a high relapse rate after with-drawal.8 The limitations of BT could be summed up as follows: dropout, or refusals 25%; no or poor effect 25%; and relapse 20% (3 months to 3 years). The controlled studies combining BT with antidepressants show a better outcome on rituals and depression in the long term. In particular, Cottraux et al63,64'1 showed fluvoxamine plus BT compared with placebo plus BT to give better results at 3 months on rituals and at. 6 months on depression with equivalent results at 1.2 and 18 months. The outcomes of the combination studies are summarized in Table III. 63-70

Table III. Obsessive-compulsive disorder: exposure with response prevention and antidepressants A, anti-exposure; CBT, cognitive behavior therapy; CMI, clomipramine; E, exposure; FLUOX, fluoxetine; FLV, fluvoxamine; IMI, imipramine; WL, waiting list; PET: positron emission tomography; PBO, placebo; R, relaxation.
Study Patients (n) Hamilton Depression Stale (17 items) Outcome
Solyom and Sookmann,65 1977 27 Short term (6 weeks)
CMI = imaginai flooding (ruminations)
CMI > thought stopping (ruminations)
CMI < E (rituals)
Marks et al,66 1980 40 17 Short term (7 weeks)
CMI + E > CMI + R
37 Long term (2 years)
CMI +E > PBO + E
at weeks 7 to 18, waning at week 36
Marks et al,67 1988 49 10 Short term (17 weeks)
CMI + E >> CMI + A
39 Long term (2 years)
CMI + E > PBO + E
at week 8. waning at week 17
Cottraux et al,63 1990 60 19 Short term (8 weeks)
FLV + E or FLV > PBO + E (rituals)
44 Mid term (24 weeks)
FLV + E or FLV > PBO + E (depression)
37 Long term (1 year)
FLV + E = PBO + E = FLV
Cottraux et al,64 1993 33 Long term (18 months)
FLV + E = PBO + E = FLV
Still under antidepressants
PBO + E and FLV + E = 18%
versus FLV = 60% (P<0.05)
Foa et al,68 1992 19 20 Short term (6 weeks)
IMI > PBO (depression)
Long term (2 years)
19 11 IMI + E = PBO + E
19 20 IMI + = E = PBO + E
Baxter et al,69 1992 18 9 Short term (10 weeks)
FLUOX = E on symptoms and reduction of right caudate hypermetabolism (PET)
Van Balkom,70 1994 104 Short term
FLV = CBT > WL (rituals)
CBT > FLV > WL (anxiety)

Long-term follow-up of CBT

When addressing the long-term follow-up question, O'Sullivan and Marks16 reviewed 9 cohorts of patients over 1 to 6 years (mean of 3 years). They found 9% dropout and 78% improvement, with a 60% mean reduction in rituals. Nonetheless, residual symptoms were a rule and liability for depression remained unchanged.

Meta-analysis of CBT

Now that BT is firmly established, several meta-analyses have been carried out. The latest meta-analysis71 included 77 studies with 4651 patients and showed that BT was superior to SSRI antidepressants as a class. Nevertheless, this difference should be taken with caution as BT is limited by the problem of availability, accessibility, and third-party payment in many countries.

CT in OCD

The status of CT is still under investigation and there have recently been some new studies published (Table IV).72-79 To date, the usefulness of CT for OCD has been assessed in 8 controlled studies. Emmelkamp et al72 did not find a superior effect, when adding cognitive modifications to in vivo exposure. Nevertheless, the design of the experiment, aimed at. teaching the patient, to replace negative thoughts by positive ones. This could have been used as neutralizing thoughts. Emmelkamp et al73 compared CT without exposure to self-managed exposure. Six months after the end of treatment, both groups showed equivalent, reduction in rituals, generalized anxiety, and social anxiety. Only the cognitive group showed change on the measures of depression. In a study with a more impaired population, Emmelkamp and Beens74 found similar results at a 6-month follow-up. Van Oppen et al75 randomized 71 patients in either Beckian CT or exposure. After 16 sessions, they found a superiority of cognitive interventions over exposure. Danger schemata were better modified by CT than with exposure. Unfortunately, this study had no long-term follow-up. A multicentered study (76) compared CT with intensive BT. Sixty-five ambulatory patients with DSM-IV OCD and without major depression were randomized into two groups for a. 16-week psychological treatment: either CT, or exposure and response prevention, for a 4-week intensive treatment period followed by a maintenance phase of 12 weeks. No medication was prescribed. At week 16, the rates of responders were comparable in the two groups. Depression (bipolar type I) was significantly more improved in the group that received CT. At weeks 26 and 52, improvement was retained in both groups without a between-group difference. Cognitive measures of obsessions changed equally in the two groups. This study replicated on a larger scale the findings of Emmelkamp and coworkers.73,74

Table VI. Cognitive therapy (CT) in obsessive-compulsive disorder: controlled studies. BT, behavior therapy; CBT; cognitive behavior therapy; ERP; exposure and response prevention; SSRI, selective serotonin reuptake inhibitor.

Study Outcome
CT versus BT (ERP)
Emmelkamp et al,72 1980 Self-instructional trainint + ERP = (follow-up 6 months)
Emmelkamp et al,73 1988 CT = ERP on rituals
CT > ERP on depression (follow-up 6 months)
Emmelkamp and Beens,74 1991 CT = ERP (follow-up 6 months)
Van Oppen et al,75 1995 CT > ERP (posttest)
Cottraux et al,76 2001 CT = ERP on rituals
CT > ERP on depression (posttest)
Comparison with a waiting list
Freeston et al,77 1997 In pure obsessions: CBT > waiting list (follow-up 6 months)
Jones and Menzies,78 1998 CT > waiting list at posttest only. No difference at 3-month follow-up
Comparison with SSRI (fluvoxamine antidepressant)
Van Balkom et al;79 1998 ERP, CT, or SSRI combined with ERP or CT: same positive outcomes at 16 weeks
Active treatments better than a waiting list at week 8

Freeston et al77 presented a study comparing a waiting list with a group treated with CBT. In a group of OCD patients with exclusively covert, rituals, that the superiority of CBT over the waiting list was maintained at 6 months' follow-up. Jones and Mcnzies78 found that CT was superior to a waiting list at. posttest only. Only one study dealt, with the problem of combination of CBT with SSRI fluvoxamine79 and found no difference between active conditions (Table IV).

In conclusion, although there is still is a clear need for more controlled studies, there is good evidence in favor of a positive effect for the cognitive approach in OCD.

Psychodynamic therapy for OCD

There is a dearth of controlled data in this field. An uncontrolled study by Kringlcn80 found that 20% of OCD patients improve during an interval ranging from 13 to 20 years versus 21 % of the patients treated with psychoanalytic therapy during the same interval.

Psychosurgery

Since the introduction of prefrontal leukotomy by Moniz,81 several techniques have been developed: stereotactic leukotomy, stereotactic cingulotomy,68,69 and the gamma-knife radiosurgery technique of capsulotomy. In general, the orbitofrontal and cingulate regions are the targets for intervention.82 However, the literature only reports series of uncontrolled case studies. About. 25% of a. panel of 33 patients who presented an intractable OCD responded in the long term.83 The side effects are severe - epilepsy, personality disorders, and depression - and there have been cases of suicide.84-86 Even the gamma-knife, which was supposed to be more precise and safer, presented detrimental effects in the form of extensive local brain necrosis after irradiation.87 There is obviously a lack of scientific evidence for a durable effect, of these techniques in a. sizeable number of severe patients. Ethical problems, low effectiveness, and side effects explain why psychosurgical decisions are under the control of ethical committees in most, of the countries.

Transcranial stimulation

There is quite limited preliminary evidence that repetitive transcranial magnetic stimulation of prefrontal areas may improve compulsive urges, which were increased after midoccipital stimulations.88 There was no difference between right, and left, brain prefrontal stimulations.89 These experiments were uncontrolled carried out in severe OCD. A positive transient response was found in only 25% of patients.

Social phobia

CBT in social phobia

Methods

Early behavioral interventions were based either on systematic desensitization or assertiveness training. Social skills deficit, was hypothesized as being at the core of performance anxiety and social phobia. SST through role play with rehearsal, shaping, and modeling by the therapist was shown to be effective in treating social phobic patients in the early seventies.

A move towards a cognitive model was the next step. According to the cognitive model of social phobia,90 cognitive factors may be particularly important in the development, and maintenance of the negative emotions and avoidance behaviors in social phobic patients. The patients assume that other people are inherently critical, and attach particular importance to being negatively appraised by others. This could be related to a basic cognitive schema of inferiority.91 CT consists in identifying negative automatic thoughts and schemata, and then modifying them by more realistic interpretations. Current, therapeutic models tend to mix cognitive and behavioral methods. The patient's evidence for his or her negative belief is cognitive ly questioned, but. emphasis is also put. on behavioral experiments to test the irrational assumptions. Treatment, classically involves about, 15 to 20 sessions in individual and/or group.

Outcomes

The effectiveness of BT on various types of social anxiety has been demonstrated in several controlled trials. Social phobia, as such, attracted the interest of clinical researchers after its inclusion in DSM-III,42-44 and was studied in controlled trials of SST, systematic desensitization, and in vivo exposure.92,93 CT, too, demonstrated its effectiveness in studies using waiting list, or other therapies as control.94-96 Two studies reported some advantages of CT combined with exposure over exposure alone,97,98 while one did not.99 Another study100 found, in a mixed sample of socially inadequate and phobic patients, that role playing and exposure were superior to cognitive restructuring at. a 6-month follow-up.

Some researchers noticed that the gains of exposure therapy were often limited by the negative influence of cognitive factors that impeded anxiety reduction.101 To deal with this problem, a. study102 designed a Cognitive Behavioral Group Treatment (CBGT), which was compared with a credible placebo: lectures and ST. At a 6month follow-up, CBGT demonstrated clearly higher effects: 75% of the patients in CBGT were improved versus 40% of those in ST. This was confirmed in follow-ups ranging between 4 and 6 years.103

A dismantling study104 comparing CBGT with exposure found that, each of the two methods was superior to a waiting list, with a slight, advantage of exposure over CT on some measures. The rate of responders was not, statistically different in the two active conditions. Surprisingly, there was no greater improvement, on cognitive measures in the CBGT group. At. a 6-month follow-up there was no longer any between-group difference.

Another trial105 showed, in limited social phobias, that CT followed by exposure, exposure followed by CT, or the combination of both had the same positive effects without significant, difference at a 3-month follow-up. The same authors106 demonstrated that CT followed by exposure was better than their combination or exposure followed by CT in generalized social phobia, at a 3month follow-up.

A meta-analysis107 of 12 CBT and 9 exposure studies concluded that CBT did not, yield better outcomes than exposure therapy, on self-report measures of social anxiety, cognitive symptoms, and depressed/anxious mood, at posttest and follow-up.

Another meta-analysis108 included 42 treatment outcome trials and tested 6 conditions: waiting list, placebo, exposure, CT, CT plus exposure, and SST. All the interventions, including placebo, produced larger effect, sizes than a waiting list, and did not. differ in dropout, proportions (12% to 18%). However, only CT associated with exposure yielded an effect, size that, was larger than placebo (1.06 versus 0.48, respectively). Exposure alone had an effect, size of 0.81, nonsignificantly different, from placebo. Effect sizes tended to improve at follow-ups.

CBT effectiveness was confirmed by Gould's metaanalysis109 in which pharmacotherapy (11 studies) had an effect, size of 0.62 versus placebo, while CBT (16 studies) reached 0.74 compared with control conditions.

In summary, meta-analytic approaches of the research suggest, that CBT is effective and exposure is a crucial component, of CBT, while the effect, of CT remains in discussion.

Medication and CBT in social phobia

Main outcome studies

Buspirone was less effective than CBT at 6 weeks in reducing performance anxiety in musicians.110 Gel ernter et al111 compared four groups: CBT, phenelzine, alprazolam, and placebo. All four groups received instruction of self-exposure. All groups improved significantly at 2 months with few differences between them. However, this equal improvement could have resulted from the exposure instructions. BT was superior to atenolol at 3 and 6 months.112 A positive combination of exposure with sertraline was found at 24 weeks. Combination was superior to placebo, but. equal to sertraline alone.113 Few differences, but, in favor of clonazepam, were found in a comparison of this BDZ with behavioral group therapy114; patients were only rated at. 4, 8, and 12 weeks.

CBGT was found to be superior to pill-placebo and educational group therapy, but. slightly inferior to phenelzine on some measures at the 12 weeks' evaluation in a randomized trial.115 Follow-up data found that, after withdrawal of the medication, CBGT was better, especially in generalized social phobia.116

Meta-analysis of CBT and medication

A meta-analysis117 of psychological and pharmacological treatments for social phobia was conducted: 108 treatment-outcome trials were entered in this meta-analysis. Eleven treatment, conditions were compared: waiting-list control, pill placebo, BDZ, SSRIs, monoamine oxidase inhibitors, attention placebo, exposure, cognitive restructuring, and applied relaxation. The most, consistently effective treatments for social phobias were pharmacotherapies. BDZs and SSRIs were equally more effective than control conditions. Dropout rates were similar among all the active treatment conditions. The durability of treatment, gains for pharmacotherapies was not assessed because of an insufficient number of drug studies with follow-up data. The treatment gains of CBT, although moderate, continued during the follow-up period. BDZs and SSRIs seem to be effective treatments for social phobia, at, least in the short, term. The authors recommended assessment, of the long-term outcome and evaluation of the inclusion of a CBT during the drug-tapering period.

Psychoanalytic therapies in performance anxiety

A randomized study by Paul118 in 1.966 in students with lack of social skills and a fear of speaking in public showed the superiority of systematic desensitization over a control (attention-placebo) and psychodynamic therapy at a 2-year follow-up. Psychodynamic therapy demonstrated no better outcomes than the waiting list. Although the study recruited a sample of students and the DSM criteria for social phobia were not. used in those days, Paul's118 study suggests a significant positive effect of systematic desensitization, and a lack of effectiveness of psychodynamic therapy, in performance anxiety.

Supportive therapy

One trial119 dealt, with a comparison of ST with CBT. The aim of the trial was to study the effectiveness of CBT versus ST carried out, “as usual.” Sixty-seven DSM-IV social phobic patients were randomly allocated into two groups. Group 1 (CBT) received eight. 1-hour sessions of individual CT for 6 weeks, followed by six 2-hour sessions of SST in group weekly. Group 2 received ST for 12 weeks (six 30-minute sessions), and then the patients were switched to CBT. No medication was prescribed. At week 6, after CT, group 1 was better than group 2 on the main social phobia measure. At, week 12, after SST, group 1 was better than group 2 on most of the measures and demonstrated a significantly higher rate of responded. This finding was replicated after switching group 2 to CBT. Sustained improvement, was observed in both groups at, follow-up. In summary, CBT was more effective than ST and had long-lasting effects.

Sympathectomy for ereuthophobia

Endothoracic sympathectomy has been carried out. for the fear of blushing120 with a questionable rationale assuming that, emotional response is mainly a peripheral problem.121 Despite early claims of high rate of success, follow-up studies were less optimistic: 67% of the patients had compensatory sweating, 50% gustatory sweating, and Horner's syndrome in 2.5%. Moreover, the number of initially satisfied patients declined over time from 98% to 66%. 122 The survey was made through a. simple questionnaire. There was no control group. It, is obvious that this is not. a treatment of choice for an anxiety problem related to a fear of blushing, more than to real blushing.

Specific phobias

CBT methods for specific phobias

Simple phobia is often considered as a normal fear, like the fear of animals or of blood. Nevertheless, it. affects 7% of the general population. In some cases, anxiety and avoidance behaviors become a handicap severe enough to lead to consultation. Treatment, classically involves about 10 to 1.5 sessions of exposure and imagination and/or in vivo and cognitive restructuring.

Outcomes

There is a lack of controlled studies. In many controlled trials, simple phobias are often part, of mixed samples of phobic patients. Follow-up studies showed a 54% improvement from baseline, which is maintained at follow-up ranging from 1 to 5 years with BT.16 Early controlled studies of CT showed negative results.123,124 A study by Getka and Glass125 compared four groups for dentist phobia: systematic desensitization, CT and stress management, interview with a warm practitioner prior to intervention, and waiting list. At. 1-year follow-up, BT and CT produced equivalent results and were superior to the two other conditions, but this needs more investigation. Virtual reality was introduced as a tool to expose height and flying phobias with positive results in a controlled study of low statistical power.126 To summarize, despite a scarce literature, in vivo exposure seems the treatment of choice for simple phobia,127 while pharmacology has not been demonstrated to have positive effects.128

Conclusion

This review shows that CBT has been proven to be effective in all the DSM-IV categories of anxiety disorders, in numerous RCT and several meta-analyses. Other forms of psychotherapy either have not been tested, or generally have lesser effects than CBT in RCTs. Surgical approaches proposed for OCD and ereuthophobia are of limited value and may have detrimental side effects, without mentioning their lack of scientific evidence. However, some words of caution may temperate this positive picture of CBT for anxiety disorders.

The cost-containment issues led the procedures to become increasingly simplified. Some attempts have been made to turn many techniques into self-help procedures, or computer-assisted therapy, or therapy administered by nurses, social workers, counselors, priests, or lay people, using treatment manuals. However, manualized therapies have limitations, especially when the therapists are facing patients with multiple DSM Axis I and Axis II problems. Those patients represent at, least 50% of the referrals in anxiety disorder units. There is obviously a limit, to simplification: computer-administered treatment appeared less effective than therapist-administered treatment in OCD.129

There are no conflicting issues between biological and psychological theoretical explanations. In practice, the combination of CBT with antidepressants has been shown to be effective in panic disorder and OCD. However, theories and practice may be in competition. CBT, due to the limited number of practitioners, even in developed countries, can be difficult to find. One of the reasons for this limited accessibility rests on the reduced CBT training opportunities in the faculties of medicine and psychology in many countries. Medication is easier to administer, hence it tends to be the first, line of intervention, despite the demonstrated efficacy and long-term effectiveness of CBT, and the fact that after stopping medication most, of the patients relapse while the outcomes of CBT are stable. In the long-term, CBT costs less than medication, as it, prevents relapses from occurring, as shown by cost-effectiveness surveys.130

Another stumbling block is the gap between basic research and practice. CBT practice is far ahead of theoretical explanations. Since the adoption of empiricism in the study of normal and abnormal psychology, we should note that the interest in fundamental psychology has tended to fade away. The first, behaviourists relied heavily on basic research works, but. the gap between practice and basic sciences has grown larger.

Marks131 recently pointed out that, as far as clinical effectiveness and efficiency are concerned, CBT is coming of age, but it, is a toddler in terms of the scientific explanations of its effects. Historically, CBT was the first, evidence-based treatment, for anxiety disorders, long before evidence-based medicine was a bandwagon,132 but now needs to be more empirically grounded. Filling this gap will be the endeavor of the 21st century researchers dedicated to the psychological approaches to anxiety disorders.

Selected abbreviations and acronyms

BDZ

benzodiazepine

BT

behavior therapy

CBT

cognitive behavior therapy

CT

congnitive therapy

EMDR

eye movement desensitization and reprocessing

GAD

generalized anxiety disorder

OCD

obsessive-compulsive disorder

PTSD

posttraumatic stress disorder

RCT

randomized controlled trial

SSRI

selective serotonin reuptake inhibitor

SST

social skills training

ST

supportive therapy

REFERENCES

  • 1.Ost LG., Westling B., Hellström K. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia. Behav Res Ther. 1993;31:383–394. doi: 10.1016/0005-7967(93)90095-c. [DOI] [PubMed] [Google Scholar]
  • 2.Ost LG., Westling B. Applied relaxation vs cognitive behavior therapy in the treatment of panic disorder. Behav Res Ther. 1995;33:145–158. doi: 10.1016/0005-7967(94)e0026-f. [DOI] [PubMed] [Google Scholar]
  • 3.Ost LG., Westling B. Applied relaxation vs cognitive behaviour therapy in the treatment of panic disorder. Behav Res Ther. 1995;33:145–158. doi: 10.1016/0005-7967(94)e0026-f. [DOI] [PubMed] [Google Scholar]
  • 4.Perroud M. Note sur l'agoraphobie. Lyon Médical. 1873;11:80–90. [Google Scholar]
  • 5.Janet P. Les obsessions et la psychasthénie . Paris, France: Alcan; 1903 [Google Scholar]
  • 6.Freud S. Lines of Advance in Psychoanalytical Psychotherapy. 1919. Standard edition, vol 17. London, UK: Hogarth Press; 1955:157–158. [Google Scholar]
  • 7.Wolpe J. The Practice of Behavior Therapy. 2nd ed. New York, NY: Pergamon Press; 1973 [Google Scholar]
  • 8.Marks I. Fears, Phobias, and Rituals: Panic, Anxiety and their Disorders. New York, NY: Oxford University Press; 1987 [Google Scholar]
  • 9.Barlow D., Craske MG. Mastery of your Anxiety and Panic. Albany, NY: Graywind Publication; 1989 [Google Scholar]
  • 10.Mattick R., Andrews G., Hadzi-Pavlovic D., et al. Treatment of panic and agoraphobia: an integrative view. J Nerv Ment Dis. 1990;178:567–576. doi: 10.1097/00005053-199009000-00003. [DOI] [PubMed] [Google Scholar]
  • 11.Cox BJ., Endler NS., Lee PS., Swinson RP. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam and in vivo exposure. J Behav Ther Exp Psychiatry. 1992;23:175–182. doi: 10.1016/0005-7916(92)90034-g. [DOI] [PubMed] [Google Scholar]
  • 12.Clum G A., Clum G., Suris RA. Meta-analysis of treatments for panic disorder. J Consult Clin Psychol. 1993;61:317–326. doi: 10.1037//0022-006x.61.2.317. [DOI] [PubMed] [Google Scholar]
  • 13.Van Balkom AJLM., Bakker A., Spinhoven P., Blaauw B., Seemk S., Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral and combination treatments, J Nerv Ment Dis. 1997;185:510–516. doi: 10.1097/00005053-199708000-00006. [DOI] [PubMed] [Google Scholar]
  • 14.Bakker A., Van Balkom A., Spinhoven P., Blaauw B., Van Dyck R. Follow-up on the treatment of panic disorder with or without agoraphobia. A quantitative review. J Nerv Ment Dis. 1998;186:414–419. doi: 10.1097/00005053-199807000-00005. [DOI] [PubMed] [Google Scholar]
  • 15.Gould RA., Otto MW., Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev. 1995;8:819–844. [Google Scholar]
  • 16.O'Sullivan G., Marks I. Long-term outcome of phobic, and obsessive-compulsive disorders after treatment. In: Noyes R, Roth M, Burrows GD, eds. Handbook of Anxiety. Vol 4. The Treatment of Anxiety. Amsterdam, The Netherlands: Elsevier; 1990 [Google Scholar]
  • 17.Zitrin C., Klein D., Woerner M. Treatment of agoraphobia with group in vivo exposure and imipramine. Arch Gen Psychiatry. 1980;37:63–72. doi: 10.1001/archpsyc.1980.01780140065007. [DOI] [PubMed] [Google Scholar]
  • 18.Telch M., Agras S., Barr-Taylor C., et al. Combined pharmacological and behavioral treatment for agoraphobia. Behav Res Ther. 1985;22:325–335. doi: 10.1016/0005-7967(85)90011-7. [DOI] [PubMed] [Google Scholar]
  • 19.Agras S. Behaviour therapy and psychopharmacology. Combined pharmacological and psychological treatment of panic disorder: current status and future direction. In: Wolf BE, Maser JD. Treatment of Panic Disorder. Washington DC: American Psychiatric Press; 1994 [Google Scholar]
  • 20.de Beurs E., van Balkom A., Lange J., Koele P., van Dyck R. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am j Psychiatry. 1995;152:683–691. doi: 10.1176/ajp.152.5.683. [DOI] [PubMed] [Google Scholar]
  • 21.Oehrberg S., Christiansen PE., Behnke K., et al. Paroxetine in the treatment for panic disorder. A randomised, double-blind, placebo-controlled trial. Br J Psychiatry. 1995;167:374–379. doi: 10.1192/bjp.167.3.374. [DOI] [PubMed] [Google Scholar]
  • 22.Sharp DM., Power KG., Simpson RJ., et al. Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord. 1996;4:219–242. [Google Scholar]
  • 23.Barlow HD., Gorman JM., Shear MK., Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000;283:2529–2536. doi: 10.1001/jama.283.19.2529. [DOI] [PubMed] [Google Scholar]
  • 24.Solyom C., Solyom I., LaPierre Y., et al. Phenelzine and exposure in the treatment of phobias. Biol Psychiatry. 1981;16:239–247. [PubMed] [Google Scholar]
  • 25.Marks I., Gray S., Cohen D., Hill R., Mawson D., Ramm L., Stern R. Imipramine and brief therapist aided exposure in agoraphobics having selfexposure homeworks. Arch Gen Psychiatry. 1983;40:153–161. doi: 10.1001/archpsyc.1983.01790020047004. [DOI] [PubMed] [Google Scholar]
  • 26.Mavissakalian M., Michelson L. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiatry. 1986;47:117–122. [PubMed] [Google Scholar]
  • 27.Fahy TJ., O'Rourke D., Brophy J., et al. The Galway study of panic disorder: clomipramine and lofepramine in DSM-3-R panic disorder. A placebocontrolled trial. J Affect Disord. 1992;25:63–76. doi: 10.1016/0165-0327(92)90094-m. [DOI] [PubMed] [Google Scholar]
  • 28.Loerch B., Graf-Morgenstern M., Hautzinger M., et al. Randomised placebocontrolled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. Br J Psychiatry. 1999;174:205–212. doi: 10.1192/bjp.174.3.205. [DOI] [PubMed] [Google Scholar]
  • 29.Marks I., Swinson R., Basoglu M., et al. Alprazolam and exposure alone or combined in panic disorder with agoraphobia: a controlled study in London and Toronto. Br J Psychiatry. 1993;162:776–787. doi: 10.1192/bjp.162.6.776. [DOI] [PubMed] [Google Scholar]
  • 30.Wardle J., Hayward P., Higgit A., et al. Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia. Behav Res Ther. 1994;32:203–215. doi: 10.1016/0005-7967(94)90113-9. [DOI] [PubMed] [Google Scholar]
  • 31.Cottraux J., Note ID., Cungi C., et al. A controlled study of cognitivebehavior therapy with buspirone or placebo in panic disorder with agoraphobia. A one-year follow-up. Br J Psychiatry. 1995;167:635–641. doi: 10.1192/bjp.167.5.635. [DOI] [PubMed] [Google Scholar]
  • 32.Otto M., Pollack MH., Sachs G., et al. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993;150:1485–1490. doi: 10.1176/ajp.150.10.1485. [DOI] [PubMed] [Google Scholar]
  • 33.Spiegel D., Bruce T., Gregg B., et al. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry. 1994;151:876–881. doi: 10.1176/ajp.151.6.876. [DOI] [PubMed] [Google Scholar]
  • 34.Barlow D., Craske M., Cerny J., et al. Behavioral treatment of panic disorder. Behav Ther. 1989;20:261–282. [Google Scholar]
  • 35.Craske M., Brown T., Barlow D. Behavioral treatment of panic disorder: a two-year follow-up. Behav Ther. 1991;22:289–304. [Google Scholar]
  • 36.Clark D., Salkovskis P., Hackmann A., Middleton H., Anastasiades P., Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994;164:759–769. doi: 10.1192/bjp.164.6.759. [DOI] [PubMed] [Google Scholar]
  • 37.Ost LG. Applied relaxation versus progressive relaxation in the treatment of panic disorder. Behav Res Ther. 1988;26:13–22. doi: 10.1016/0005-7967(88)90029-0. [DOI] [PubMed] [Google Scholar]
  • 38.Arntz A., Van den Hout M. Psychological treatment of panic disorder without agoraphobia: cognitive therapy versus applied relaxation. Behav Res Ther. 1996;34:113–121. doi: 10.1016/0005-7967(95)00061-5. [DOI] [PubMed] [Google Scholar]
  • 39.Beck AT., Sokol L., Clark DA., et al. A cross-over of focused cognitive therapy for panic disorder. Am J Psychiatry. 1992;149:778–783. doi: 10.1176/ajp.149.6.778. [DOI] [PubMed] [Google Scholar]
  • 40.Shear K., Pilkonis P., Cloitre M., et al. Cognitive-behavioral treatment compared with nonprescriptive treatment of panic disorder. Arch Gen Psychiatry. 1994;51:395–401. doi: 10.1001/archpsyc.1994.03950050055006. [DOI] [PubMed] [Google Scholar]
  • 41.Wiborg IM., Dahl AA. Does brief dynamic therapy reduce the relapse rate of panic disorder. Arch Gen Psychiatry. 1996;53:689–694. doi: 10.1001/archpsyc.1996.01830080041008. [DOI] [PubMed] [Google Scholar]
  • 42.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980 [Google Scholar]
  • 43.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987 [Google Scholar]
  • 44.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994 [Google Scholar]
  • 45.Wells A. Cognitive Therapy for Anxiety Disorders. A Practice Manual and Conceptual Guide. Chichester, UK: John Wiley and Sons; 1997 [Google Scholar]
  • 46.Gould RA., Buckminster S., Pollack MH., Otto MW., Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clin Psychol Sci Pract. 1997;4:291–306. [Google Scholar]
  • 47.Gould RA., Otto MW., Pollack MH., Yay L. Cognitive behavioural and pharmacological treatment of generalized anxiety disorder: a preliminary metaanalysis. Behav Ther. 1997;28:285–305. [Google Scholar]
  • 48.Durham R., Murphy T., Allan T., Richard K., Treliving L., Fenton G. Cognitive therapy, analytic psychotherapy and anxiety management for anxiety management training for anxiety disorder. Br J Psychiatry. 1994;165:315–323. doi: 10.1192/bjp.165.3.315. [DOI] [PubMed] [Google Scholar]
  • 49.White J., Keenan M., Brooks N. Stress control: a controlled comparative investigation of large group therapy for generalized anxiety disorder. Behav Psychother. 1992;20:97–114. [Google Scholar]
  • 50.Borkovec TD., Mathews AM., Chambers A., Ebrahami S., Lytle R., Nelson R. The effects of relaxation training with cognitive or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. J Consult Clin Psychol. 1987;55:883–888. doi: 10.1037//0022-006x.55.6.883. [DOI] [PubMed] [Google Scholar]
  • 51.Borkovec TD., Costello E. Efficacy of applied relaxation and Cognitive-behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1993;61:611–619. doi: 10.1037//0022-006x.61.4.611. [DOI] [PubMed] [Google Scholar]
  • 52.Blowers C., Cobb J., Mathews A. Generalised anxiety: a controlled treatment study. Behav Res Ther. 1987;25:493–502. doi: 10.1016/0005-7967(87)90057-x. [DOI] [PubMed] [Google Scholar]
  • 53.Stanley MA., Beck JG., Glassco JD. Treatment of generalized anxiety in older adults: a preliminary comparison of cognitive-behavioral and supportive approaches. Behav Ther. 1996;27:565–581. [Google Scholar]
  • 54.Wilson SA., Becker LA., Tinker RH. Eye movement desensitization and reprocessing (EMDR) treatment for psychologically traumatized individuals. J Consult Clin Psychol. 1995;63:928–937. doi: 10.1037//0022-006x.63.6.928. [DOI] [PubMed] [Google Scholar]
  • 55.Devilly GJ., Spence SH., Rapee R. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav Ther. 1998:435–455. [Google Scholar]
  • 56.Marks IM., Lovell K., Noshirvani H., Livanou M., Trasher S. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring. Arch Gen Psychiatry. 1998;5:317–325. doi: 10.1001/archpsyc.55.4.317. [DOI] [PubMed] [Google Scholar]
  • 57.Van Etten ML., Taylor S. Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis. Clin Psychol Psychother . 1998;5:126–144. [Google Scholar]
  • 58.Brom D., Kleber RJ., Defares PB. Brief psychotherapy for post-traumatic stress disorders. J Consult Clin Psychol. 1989;57:607–612. doi: 10.1037//0022-006x.57.5.607. [DOI] [PubMed] [Google Scholar]
  • 59.Mitchell JT. When disaster strikes ... the critical incidents stress debriefing process. J Emerg Med Serv. 1983;8:36–39. [PubMed] [Google Scholar]
  • 60.Rose S., Bisson J., Wessely S. Psychological debriefing for preventing posttraumatic stress disorder (PTSD). The Cochrane Library, Issue 3. Oxford, UK: Update Software, http://www.update-software.com/abstracts/ab000560.htm. Accessed 24 July 2002. [Google Scholar]
  • 61.Meyer V. Modifications of expectations in cases with obsessional rituals. Behav Res Ther. 1966;4:273–280. doi: 10.1016/0005-7967(66)90023-4. [DOI] [PubMed] [Google Scholar]
  • 62.Salkovskis PM. Obsessional-compulsive problems. A cognitive-behavioral analysis. Behav Res Ther. 1985;23:571–583. doi: 10.1016/0005-7967(85)90105-6. [DOI] [PubMed] [Google Scholar]
  • 63.Cottraux J., Mollard E., Bouvard M., et al. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol. 1990;5:17–30. doi: 10.1097/00004850-199001000-00002. [DOI] [PubMed] [Google Scholar]
  • 64.Cottraux J., Mollard E., Bouvard M., Marks I. Exposure therapy, fluvoxamine or combination treatment in obsessive-compulsive disorder: 1-year follow-up. Psychiatry Res. 1993;49:63–75. doi: 10.1016/0165-1781(93)90030-k. [DOI] [PubMed] [Google Scholar]
  • 65.Solyom L., Sookman D. A comparison of clomipramine hydrochloride (Anafranil) and behaviour therapy in the treatment of obsessive neurosis. J Int Med Res. 1977;5(suppl 5):49–61. [PubMed] [Google Scholar]
  • 66.Marks I., Stern RS., Mawson D., Cobb J., McDonald R. Clomipramine and exposure for obsessive-compulsive rituals. Br J Psychiatry. 1980;136:1–25. doi: 10.1192/bjp.136.1.1. [DOI] [PubMed] [Google Scholar]
  • 67.Marks I., Lelliott P., Basoglu M., Noshirvani H., Monteiro W., Kasvikis Y. Clomipramine, self-exposure and therapist-aided exposure in obsessive-compulsive ritualisers. Br J Psychiatry. 1988;152:522–534. doi: 10.1192/bjp.152.4.522. [DOI] [PubMed] [Google Scholar]
  • 68.Foa E., Kozak M., Steketee G., McCarthy PR. Treatment of depressive and obsessive-compulsive symptoms in obsessive-compulsive disorder by imipramine and behaviour therapy. Br J Clin Psychol. 1992;31:279–292. doi: 10.1111/j.2044-8260.1992.tb00995.x. [DOI] [PubMed] [Google Scholar]
  • 69.Baxter L., Schwartz J., Bergman K., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:681–689. doi: 10.1001/archpsyc.1992.01820090009002. [DOI] [PubMed] [Google Scholar]
  • 70.Van Balkom A. Comparative Treatment Studies in Panic Disorder with Agoraphobia and Obsessive-Compulsive Disorder. Thesis. Amsterdam, The Netherlands: Vrije Universiteit Amsterdam; 1994 [Google Scholar]
  • 71.Kobak KA., Greist JH., Jefferson JW., Katzlenick DJ., Henk HJ. Behavioral versus pharmacological treatments of obsessive-compulsive disorder. Psychopharmacology. 1998;3:205–216. doi: 10.1007/s002130050558. [DOI] [PubMed] [Google Scholar]
  • 72.Emmelkamp P., Van der Helm M., Van Zanten B., Plochg I. Contribution of self-instructional training to the effectiveness of exposure in vivo: a comparison with obsessive-compulsive patients. Behav Res Ther. 1980;18:61–66. doi: 10.1016/0005-7967(80)90070-4. [DOI] [PubMed] [Google Scholar]
  • 73.Emmelkamp P., Visser S., Hoekstra RJ. Cognitive therapy versus in vivo exposure in the treatment of obsessive-compulsive patients. Cogn Ther Res. 1988;12:103–114. [Google Scholar]
  • 74.Emmelkamp P., Beens H. Cognitive therapy with obsessive-compulsive disorder: a comparative evaluation. Behav Res Ther. 1991;29:293–300. doi: 10.1016/0005-7967(91)90120-r. [DOI] [PubMed] [Google Scholar]
  • 75.Van Oppen P., de Haan E., Van Balkom AJ., Spinhoven P., Hogduin K., Van Dyck R. Cognitive therapy and exposure in vivo in the treatment of obsessive-compulsive disorder. Behav Res Ther. 1995;33:379–390. doi: 10.1016/0005-7967(94)00052-l. [DOI] [PubMed] [Google Scholar]
  • 76.Cottraux J., Ivan Note I., Yao SN., et al. A randomized controlled trial of cognitive therapy versus intensive behaviour therapy in obsessive-compulsive disorder subjects. Psychother Psychosomatics. 2001;70:288–297. doi: 10.1159/000056269. [DOI] [PubMed] [Google Scholar]
  • 77.Freeston MH., Ladouceur R., Gagnon F., et al. Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol. 1997;65:405–413. doi: 10.1037//0022-006x.65.3.405. [DOI] [PubMed] [Google Scholar]
  • 78.Jones MK., Menzies RG. Danger ideation reduction therapy (DIRT) for obsessive-compulsive washers, controlled trial. Behav Res Ther. 1998;36:959–970. doi: 10.1016/s0005-7967(98)00057-6. [DOI] [PubMed] [Google Scholar]
  • 79.Van Balkom AJLM., De Haan E., Van Oppen P., Spinhoven P., Hogduin KAL., Van Dyck R. Cognitive and behavioral therapies alone or in combination with fluvoxamine in the treatment of obsessive-compulsive disorder. J Nerv Ment Dis. 1998;186:492–498. doi: 10.1097/00005053-199808000-00007. [DOI] [PubMed] [Google Scholar]
  • 80.Kringlen E. Obsessional neurotics: a long-term follow-up. Br J Psychiatry. 1965;111:709–722. doi: 10.1192/bjp.111.477.709. [DOI] [PubMed] [Google Scholar]
  • 81.Moniz E. Prefrontal leucotomy in the treatment of mental disorder (May, 1937). Am J Psychiatry. 1994;151:237–239. doi: 10.1176/ajp.151.6.236. [DOI] [PubMed] [Google Scholar]
  • 82.Ballantine H., Bouckoms A., Thomas E., Giriunas I. Treatment of psychiatric illness by stereotaxic cingulotomy. Biol Psychiatry. 1987;22:807–819. doi: 10.1016/0006-3223(87)90080-1. [DOI] [PubMed] [Google Scholar]
  • 83.Baer L., Rauch S., Ballantine T., et al. Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients. Arch Gen Psychiatry. 1995;52:384–392. doi: 10.1001/archpsyc.1995.03950170058008. [DOI] [PubMed] [Google Scholar]
  • 84.Mindus P., Rasmussen SA., Lindquist C. Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J Neuropsychiatry Clin Neurosci. 1994;6:467–477. doi: 10.1176/jnp.6.4.467. [DOI] [PubMed] [Google Scholar]
  • 85.Hay P., Sachdev P., Gumming S., Smith JS., Kitchener P., Matheson J. Treatment of obsessive-compulsive disorder by psychosurgery. Acta Psychiatr Scand. 1993;87:197–207. doi: 10.1111/j.1600-0447.1993.tb03356.x. [DOI] [PubMed] [Google Scholar]
  • 86.Jenike MA., Baer L., Ballantine T., et al. Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch Gen Psychiatry. 1991;48:548–555. doi: 10.1001/archpsyc.1991.01810300060009. [DOI] [PubMed] [Google Scholar]
  • 87.Kihkström L., Guo WY., Lindquist C., Mindus P. Radiobiology of radiosurgery for refractory anxiety disorders. Neurosurgery. 1995;36:294–302. doi: 10.1227/00006123-199502000-00008. [DOI] [PubMed] [Google Scholar]
  • 88.Greenberg BD., George MS., Martin JD., et al. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry. 1997;154:867–869. doi: 10.1176/ajp.154.6.867. [DOI] [PubMed] [Google Scholar]
  • 89.Sachdev PS., McBride R., Loo CK., Mitchell PB., Malhi GS., Croker VM. Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry. 2001;62:981–984. doi: 10.4088/jcp.v62n1211. [DOI] [PubMed] [Google Scholar]
  • 90.Beck AT., Emery G., Greenberg R. Anxiety Disorders and Phobias. A Cognitive Perspective. New York, NY: Basic Books; 1985 [Google Scholar]
  • 91.Yao SN., Cottraux J., Martin R., et al. Inferiority in social phobies, obsessive-compulsive and non-clinical controls. A controlled study with the inferiority scale. In: Sanavio E, ed. Behaviour and Cognitive Therapy Today: Essays in Honour of Hans J. Eysenck. London, UK: Elsevier; 1998 [Google Scholar]
  • 92.Marzillier J., Lambert C., Kellett J. A controlled evaluation of systematic desensitization and social skills training for socially inadequate psychiatric patients. Behav Ther Res. 1976;14:225–238. doi: 10.1016/0005-7967(76)90015-2. [DOI] [PubMed] [Google Scholar]
  • 93.Butler G., Cullington A., Monby M. Exposure and anxiety management in the treatment of social phobias. J Clin Psychol. 1984;52:642–650. doi: 10.1037//0022-006x.52.4.642. [DOI] [PubMed] [Google Scholar]
  • 94.Shaw P. A comparison of three behaviour therapies in the treatment of social phobia. Br J Psychiatry . 1979;134:620–623. doi: 10.1192/bjp.134.6.620. [DOI] [PubMed] [Google Scholar]
  • 95.Kanter NJ., Golfried MR. Relative effectiveness of rational restructuring and self-control desensitization in the reduction of interpersonal anxiety. Behav Ther. 1979;10:472–490. [Google Scholar]
  • 96.Emmelkamp PMG., Mersch PP., Vissia E., Van der Helm M. Social phobia: a comparative evaluation of cognitive and behavioural interventions. Behav Res Ther. 1985;23:365–369. doi: 10.1016/0005-7967(85)90015-4. [DOI] [PubMed] [Google Scholar]
  • 97.Jerremalm A., Jansson L., Ost LG. Cognitive and physiological reactivity and the effects of different behavioural methods in the treatment of social phobias. Behav Res Ther. 1986;24:171–180. doi: 10.1016/0005-7967(86)90088-4. [DOI] [PubMed] [Google Scholar]
  • 98.Biran M., Wilson GT. Treatment of phobic disorders using cognitive and exposure methods: a self-efficacy analysis. J Consult Clin Psychol. 1981;49:886–899. doi: 10.1037//0022-006x.49.6.886. [DOI] [PubMed] [Google Scholar]
  • 99.Mattick R., Peters L., Clarke C. Exposure and cognitive restructuring for social phobia: a controlled study. Behav Ther. 1989;20:3–23. [Google Scholar]
  • 100.Stravinsky A., Marks I., Yule W. Social skills problems in neurotic outpatients. Arch Gen Psychiatry. 1982;39:1378–1385. doi: 10.1001/archpsyc.1982.04290120014003. [DOI] [PubMed] [Google Scholar]
  • 101.Butler G. Exposure as a treatment for social phobia: some instructive difficulties. Behav Res Ther. 1985;23:651–657. doi: 10.1016/0005-7967(85)90060-9. [DOI] [PubMed] [Google Scholar]
  • 102.Heimberg R., Dodge C., Hope D., Kennedy C., Zollo L. Cognitive behavioural group treatment for social phobia: comparison with a credible placebo control. Cogn Ther Res. 1990;14:1–23. [Google Scholar]
  • 103.Heimberg R., Salzman D., Holt C., Blendell K. Cognitive-behavioral group treatment for social phobia: effectiveness a five-year follow-up. Cogn Ther Res. 1993;17:325–339. [Google Scholar]
  • 104.Hope DA., Heimberg RG., Bruch MA. Dismantling cognitive-behavioral group therapy for social phobia. Behav Res Ther. 1995;33:637–650. doi: 10.1016/0005-7967(95)00013-n. [DOI] [PubMed] [Google Scholar]
  • 105.Emmelkamp PMG., Scholing A. Cognitive and behavioural treatments of fear of blushing, sweating or trembling. Behav Res Ther. 1993;31:155–170. doi: 10.1016/0005-7967(93)90067-5. [DOI] [PubMed] [Google Scholar]
  • 106.Scholing A., Emmelkamp PMG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther. 1993;31:667–681. doi: 10.1016/0005-7967(93)90120-j. [DOI] [PubMed] [Google Scholar]
  • 107.Feske U., Chambless DL. Cognitive behavioural versus exposure only treatment for social phobia. Behav Ther. 1995;26:695–720. [Google Scholar]
  • 108.Taylor S. Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry. 1996;27:1–9. doi: 10.1016/0005-7916(95)00058-5. [DOI] [PubMed] [Google Scholar]
  • 109.Gould RA., Buckminster S., Pollack MH., Otto MW., Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clin Psychol Sci Pract. 1997;4:291–306. [Google Scholar]
  • 110.Clark DB., Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry. 1991;148:598–605. doi: 10.1176/ajp.148.5.598. [DOI] [PubMed] [Google Scholar]
  • 111.Gerlemter C., Uhde T., Cimbolic P., et al. Cognitive-behavioural and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry. 1991;48:938–945. doi: 10.1001/archpsyc.1991.01810340070009. [DOI] [PubMed] [Google Scholar]
  • 112.Turner SM., Beidel DC., Jacob RG. Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol. 1994;62:350–358. doi: 10.1037//0022-006x.62.2.350. [DOI] [PubMed] [Google Scholar]
  • 113.Blomhoff S., Haug TT., Hellstrom K., et al. Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry. 2001;179:23–30. doi: 10.1192/bjp.179.1.23. [DOI] [PubMed] [Google Scholar]
  • 114.Otto MW., Pollack MH., Gould RA., Worthington JJ., McArdle ET., Rosenbaum JF. A comparison of the efficacy of clonazepam and Cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord. 2000;14:345–358. doi: 10.1016/s0887-6185(00)00027-x. [DOI] [PubMed] [Google Scholar]
  • 115.Heimberg R., Liebowitz M., Hope D., et al. Cognitive-behavioral group therapy vs phenelzine therapy for social phobia. Arch Gen Psychiatry. 1998;55:1133–1141. doi: 10.1001/archpsyc.55.12.1133. [DOI] [PubMed] [Google Scholar]
  • 116.Liebowitz RM., Heimberg R., Schneier FR., et al. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depression Anxiety. 1999;10:89–98. [PubMed] [Google Scholar]
  • 117.Fedoroff IC., Taylor S. Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol. 2001;21:311–324. doi: 10.1097/00004714-200106000-00011. [DOI] [PubMed] [Google Scholar]
  • 118.Paul G. Insight Versus Desensitization in Psychotherapy. Stanford, Calif: Stanford University Press; 1966 [Google Scholar]
  • 119.Cottraux J., Note I., Albuisson E., et al. Cognitive behaviour therapy versus supportive therapy in social phobia: a randomised controlled trial. Psychother Psychosomatics. 2000;69:137–146. doi: 10.1159/000012382. [DOI] [PubMed] [Google Scholar]
  • 120.Yilmaz EN., Dur AHM., Cuesta MA., Rauwerda JA. Endoscopic versus transaxillary thoracic sympathectomy for primary axillary and palmar hyperhidrosis and/or facial blushing: 5-year experience. Eur J Cardiothorac Surg. 1996;10:168–172. doi: 10.1016/s1010-7940(96)80292-2. [DOI] [PubMed] [Google Scholar]
  • 121.Drummond PD., Lance JW. Facial flushing and sweating mediated by the sympathetic nervous system. Brain. 1987;110:793–803. doi: 10.1093/brain/110.3.793. [DOI] [PubMed] [Google Scholar]
  • 122.Herbst F., Plas EG., Függer R., Fritsch A. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs: a critical analysis and long-term results of 480 operations. Ann Surg. 1994;220:86–90. doi: 10.1097/00000658-199407000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Ladouceur R. Participant modeling with or without cognitive treatment for phobias. J Consult Clin Psychol. 1983;51:942–944. [PubMed] [Google Scholar]
  • 124.Biran M., Wilson GT. Treatment of phobic disorders using cognitive and exposure methods: a self-efficacy analysis. J Consult Clin Psychol. 1981;49:886–899. doi: 10.1037//0022-006x.49.6.886. [DOI] [PubMed] [Google Scholar]
  • 125.Getka EJ., Glass CR. Behavioural and cognitive-behavioural approaches to the reduction of dental anxiety. Behav Ther. 1992;23:433–448. [Google Scholar]
  • 126.Rothbaum BO., Hodges LF., Kooper R., Opdyke D., Williford JS., North M. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia. Am J Psychiatry. 1995;1 52:626–628. doi: 10.1176/ajp.152.4.626. [DOI] [PubMed] [Google Scholar]
  • 127.Rachman SJ. In: Salkovskis PM, ed. Trends in Cognitive and Behavioural Therapy. Chichester, UK: John Wiley and Sons Ltd; 1996 [Google Scholar]
  • 128.Zitrin C., Klein D., Woerner M. Behaviour therapy, supportive psychotherapy, imipramine and phobias. Arch Gen Psychiatry. 1978;35:307–316. doi: 10.1001/archpsyc.1978.01770270057005. [DOI] [PubMed] [Google Scholar]
  • 129.Greist JH., Marks IM., Baer L., et al. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry. 2002;63:138–145. doi: 10.4088/jcp.v63n0209. [DOI] [PubMed] [Google Scholar]
  • 130.Miller NE., Magruder KM. Cost-effectiveness of psychotherapy . Oxford, UK: Oxford University Press; 1999:224–234. [Google Scholar]
  • 131.Marks IM. The maturing of therapy: some brief psychotherapies help anxiety/depressive disorders but mechanisms of action are unclear. Br J Psychiatry. 2002;180:200–204. doi: 10.1192/bjp.180.3.200. [DOI] [PubMed] [Google Scholar]
  • 132.Salkovskis PM. Empirically grounded clinical interventions: cognitive-behavioural therapy progresses through a multi-dimensional approach to clinical science. Behav Cogn Psychother. 2002;30:3–9. [Google Scholar]

Articles from Dialogues in Clinical Neuroscience are provided here courtesy of Taylor & Francis

RESOURCES